PF-3758309
PF-3758309 (PF-03758309) is a potent, orally available, and reversible ATP-competitive inhibitor of PAK4 (Kd= 2.7 nM; Ki=18.7 nM) . PF-3758309 has the expected cellular functions of a PAK4 inhibitor: inhibition of anchorage-independent growth, induction of apoptosis, cytoskeletal remodeling, and inhibition of proliferation[1][2][3].
Product Specifications
CAS Number
898044-15-0
Product Name Alternative
PF-03758309
UNSPSC
12352005
Hazard Statement
H302, H317
Target
Apoptosis; PAK
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Cytoskeleton
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/PF-3758309.html
Concentration
10mM
Purity
99.79
Solubility
DMSO : ≥ 100 mg/mL
Smiles
CC1=NC2=C(SC=C2)C(NC3=NNC4=C3CN(C(N[C@@H](C5=CC=CC=C5)CN(C)C)=O)C4(C)C)=N1
Molecular Formula
C25H30N8OS
Molecular Weight
490.62
Precautions
H302, H317
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Isoform
PAK1; PAK2; PAK3; PAK4; PAK5; PAK6
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
3-Aminophthalic Acid Hydrochloride Dihydrate, Technical Grade
MART-1 / Melan-A (A103), CF568 conjugate, 0.1mg/mL
